skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

An analysis of reported cases shoulder injury related to vaccine administration of after COVID-19 vaccination

Human vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2321672-2321672 [Peer Reviewed Journal]

2024 The Author(s). Published with license by Taylor & Francis Group, LLC. 2024 The Author(s) ;ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2024.2321672 ;PMID: 38439670

Full text available

Citations Cited by
  • Title:
    An analysis of reported cases shoulder injury related to vaccine administration of after COVID-19 vaccination
  • Author: Li, Zixin ; Chen, Shijie ; Zhao, Mingyi
  • Subjects: Adult ; Aged ; Aged, 80 and over ; BNT162 Vaccine ; ChAdOx1 nCoV-19 ; clinical characteristics ; Coronavirus ; COVID-19 - prevention & control ; COVID-19 vaccine ; COVID-19 Vaccines - adverse effects ; Female ; Humans ; Male ; Middle Aged ; shoulder injury ; SIRVA ; treatment outcomes ; Vaccination - adverse effects ; Young Adult
  • Is Part Of: Human vaccines & immunotherapeutics, 2024-12, Vol.20 (1), p.2321672-2321672
  • Description: To prevent COVID-19, the COVID-19 vaccine has been widely administered worldwide, but various complications accompany this vaccine. The aim of this study was to investigate the demographic patterns, clinical features, diagnostic findings, and treatment outcomes associated with shoulder injury related to vaccine administration (SIRVA). This study examined 22 patients with SIRVA following COVID-19 vaccination from the Web of Science (WOS) and PubMed databases. The patients were categorized based on sex, age, type of COVID-19 vaccine received, dose administered, latency of symptom onset, and the presence of specific clinical manifestations. Patients, evenly distributed by sex (12 females, 10 males), and aged 21 to 84 years (mean age 46.6), were analyzed. SIRVA cases were reported across all age groups. The Pfizer - BioNTech COVID-19 vaccine had the highest incidence (  = 8), followed by the Oxford/AstraZeneca COVID-19 vaccine (  = 4). Symptoms, primarily shoulder pain (  = 22) and shoulder mobility disorders (  = 18), occurred within three days post-vaccination. Some patients also reported shoulder swelling (  = 5) and fever (  = 2). Imaging revealed nonspecific X-ray findings, supraspinatus tendon calcification (  = 2), and shoulder edema and inflammation on MRI (  = 12). This study provides insights into the clinical aspects of SIRVA related to COVID-19 vaccination. Recognition and appropriate management of these complications are crucial for optimal patient outcomes.
  • Publisher: United States: Taylor & Francis
  • Language: English
  • Identifier: ISSN: 2164-5515
    EISSN: 2164-554X
    DOI: 10.1080/21645515.2024.2321672
    PMID: 38439670
  • Source: MEDLINE
    DOAJ Directory of Open Access Journals
Back to results list
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait